Masimo Corporation $MASI Shares Bought by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP lifted its stake in shares of Masimo Corporation (NASDAQ:MASI) by 20.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,419,250 shares of the medical equipment provider’s stock after acquiring an additional 238,047 shares during the quarter. Masimo accounts for 0.9% of Westfield Capital Management Co. LP’s portfolio, making the stock its 22nd largest holding. Westfield Capital Management Co. LP owned 2.64% of Masimo worth $209,410,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. MAI Capital Management boosted its position in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 136 shares during the period. Allworth Financial LP increased its position in shares of Masimo by 72.8% in the second quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after acquiring an additional 163 shares in the last quarter. Clearstead Advisors LLC raised its holdings in shares of Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73 shares during the period. Finally, Quantbot Technologies LP acquired a new stake in shares of Masimo during the second quarter valued at approximately $86,000. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Price Performance

NASDAQ MASI opened at $175.10 on Thursday. Masimo Corporation has a fifty-two week low of $125.94 and a fifty-two week high of $194.88. The stock’s 50-day moving average is $141.50 and its two-hundred day moving average is $143.65. The firm has a market cap of $9.40 billion, a P/E ratio of -16.61, a price-to-earnings-growth ratio of 1.78 and a beta of 1.26. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.84 and a quick ratio of 1.92.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Monday, December 1st. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research report on Tuesday, February 17th. Bank of America initiated coverage on Masimo in a research report on Monday, November 17th. They set a “neutral” rating and a $162.00 price target on the stock. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Wells Fargo & Company lowered Masimo from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $190.00 to $180.00 in a research report on Wednesday, February 18th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Masimo currently has a consensus rating of “Hold” and a consensus target price of $181.17.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.